Products

WellQuestPro is a clinician-centered longitudinal intelligence platform for licensed healthcare professionals in oncology, urology, and primary care. Unlike point-in-time clinical AI tools, WellQuestPro tracks patients across every encounter — surfacing what changed since the last visit, what has worsened over time, and what still lacks follow-up. What makes WellQuestPro different Every clinical AI platform answers the question in front of the clinician. WellQuestPro answers the questions the cl

Significo is a Healthcare Software and App Development Firm specializing in creating evidence-based apps, tools, and platforms that empower patients to make positive changes, improve their health outcomes and lower the cost of care. Founded by Rick McCartney, a psychiatric nurse practitioner with a doctorate of nursing practice, Significo is on a mission to humanize healthcare by combining clinical know-how with scaling technology. Significo works exclusively in the healthcare space on health

Rejuvenation Technologies Inc. is a biotechnology company dedicated to developing innovative therapies aimed at extending human healthspan and lifespan. Their primary focus is on advancing treatments that target the fundamental mechanisms of aging, with the goal of delaying or reversing age-related diseases and conditions. Key Features and Functionality: - Telomerase Activation: The company is pioneering therapies that activate telomerase, an enzyme that extends telomeres, thereby promoting ce

Vineti is the essential software solution to drive and scale personalized therapies, such as Cell and Gene Therapies or Cancer Vaccines.

Deckshare.ai is a secure data room and session intelligence platform engineered for high-stakes fundraising, corporate development, and intellectual property due diligence. Traditional sharing platforms often compress video files, break inline previews, or lock critical tracking metrics behind expensive enterprise tiers. We engineered Deckshare to eliminate this friction, providing deep asset security natively on a unified stack for a flat rate of $10/month. Key Capabilities: 1. Granular Sess

Zelthy Cell & Gene Therapy Orchestration is an application for managing the full lifecycle of cell and gene therapies from patient identification through long-term follow-up. It coordinates every stakeholder — treatment centers, manufacturers, couriers, and care coordinators — on a single platform, managing scheduling dependencies, chain-of-custody tracking, REMS compliance, and infusion logistics for therapies like CAR-T, gene therapy, and other advanced treatment modalities.

Apprentice’s manufacturing execution system scales your complex manufacturing by applying emerging technology to your production process. Our MES integrates wearable and mobile devices, augmented reality, artificial intelligence, and voice recognition into one easy-to-use platform that ensures your operators efficiently deliver a high-quality batch while being flexible enough to adapt your production to ever-changing drug therapies. Accelerate consistent, high-quality manufacturing for batches o

Exscientia is a pioneering AI-driven pharmatech company dedicated to revolutionizing drug discovery and development. By integrating artificial intelligence, automation, and patient-centric data, Exscientia accelerates the creation of effective medicines, aiming to deliver the best possible drugs in the most efficient manner. Their innovative approach has led to the first AI-designed small molecules entering clinical trials, demonstrating a significant advancement in pharmaceutical research. Key

Ochre Bio is a biotechnology company dedicated to developing RNA-based therapies for chronic liver diseases, aiming to eliminate the necessity for liver transplants. By integrating advanced genomics, artificial intelligence, and experimental biology, Ochre Bio focuses on creating treatments that regenerate diseased livers and enhance donor liver viability. Key Features and Functionality: - Human Discovery Platform: Ochre Bio has invested over $20 million to build comprehensive human liver data

CoinTrapper is an AI-powered platform designed to provide cryptocurrency traders with real-time trading signals and market insights. By leveraging advanced machine learning algorithms, CoinTrapper analyzes vast amounts of market data to identify profitable trading opportunities, helping users make informed decisions in the volatile crypto market. Key Features and Functionality: - Real-Time Trading Signals: Delivers up-to-date buy and sell signals based on comprehensive market analysis. - AI-Dr

First Ascent Biomedical is a pioneering biotech company dedicated to transforming oncology through its innovative Drug Prediction Platform (DxPP). This first-of-its-kind system integrates functional drug testing, DNA/RNA sequencing, and AI-driven tumor analysis to develop personalized treatment plans for cancer patients. By rapidly growing therapy-resistant cells from patient samples and testing them against hundreds of FDA-approved drugs, DxPP identifies the most effective therapies tailored to

Protai is an AI-powered drug discovery startup that integrates deep proteomics with machine learning to revolutionize the development of new therapies. By analyzing proteins in their native states, Protai aims to transform disease treatment by identifying unique disease drivers and developing innovative strategies for breakthrough therapies and improved patient outcomes. Key Features and Functionality: - AIMS™ Platform: Protai's proprietary drug discovery engine combines structural and functio

The solution enhances traditional weekly level demand planning by utilizing daily level data from the TradeEdge platform and a variety of other current information. The solution runs on SAP BTP, making it scalable and suitable for organizations of all sizes.

Mytos is revolutionizing regenerative medicine by providing automated manufacturing solutions that enable scalable, consistent, and cost-effective production of cell-based therapies. Their proprietary iDEM™ technology automates all unit operations in cell culture, including coating, seeding, feeding, imaging, passaging, and harvesting, while maintaining the biological integrity of the cells. This automation reduces labor per batch by up to tenfold and minimizes cleanroom footprint, ensuring cons

Precigenetics is a biotechnology company revolutionizing drug discovery by providing real-time insights into epigenetic changes, thereby eliminating guesswork in precision medicine and targeted therapies. Their proprietary platform, COMPASS, enables real-time single-cell analysis of epigenetic mechanisms, offering unprecedented understanding of how cells regulate and adapt in response to diseases and treatments. Key Features and Functionality: - Real-time Analysis: Facilitates immediate observ

Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company dedicated to transforming mental health treatment by developing innovative, rapid-acting, and durable therapies. Founded in 2019 and headquartered in New York, the company focuses on creating novel chemical entities (NCEs) that address the root causes of psychiatric disorders, moving beyond traditional symptom management. Key Features and Functionality: - NMDAR Antagonists: Gilgamesh is developing orally bioavailable, rapid-ac

Intelligencia AI offers a suite of AI-powered solutions designed to de-risk drug development and enhance decision-making in the pharmaceutical industry. By integrating proprietary data with advanced machine learning algorithms, Intelligencia AI provides accurate assessments of a drug's probability of technical and regulatory success (PTRS). This approach addresses the industry's challenges of lengthy development timelines, high costs, and low approval rates, enabling companies to make informed d

Eris Biotech is a biotechnology company dedicated to developing innovative cancer therapies that harness the body's immune system to combat malignancies. Recognizing that cancer cells often evade immune detection, leading to treatment failures, Eris Biotech has identified a novel pathway to counteract this immune evasion. Their flagship product is a first-in-class, orally administered small-molecule inhibitor designed to reawaken the immune response against cancer cells. This approach does not r

Parexel is focused on the development of innovative new therapies to improve the worlds health.

Somite is leveraging data and AI to introduce novel cell replacement therapies.